So proud of this crew 🤩

Thanks for sharing Ashish M. Kamat, MD, MBBS the APPs have indeed major role & huge contributions in patient care, research, education, outreach, etc. Amer. Urol. Assn. MD Anderson Cancer Center
Fred Hutchinson Cancer Center UW Urology OncoAlert UroToday.com Sarah P. Psutka MD MS Dimitra Bakaloudi MD, MS Dr. Bishoy M. Faltas Shilpa Gupta Pavlos Msaouel

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Prof Param Mariappan Ashish M. Kamat, MD, MBBS Shilpa Gupta Petros Grivas IBCG Bladder Cancer Advocacy Network Janet Kukreja Amanda Myers Andrea Necchi Sarah P. Psutka MD MS Jeremy Teoh Jennifer Regala Yüksel Ürün OncLive.com Love this! #NoOneWalksAlone !

IBCG Karima Oualla, MD,MSc Shilpa Gupta Ashish M. Kamat, MD, MBBS Amanda Myers Janet Kukreja Petros Grivas Patrick Hensley, MD Sima Porten Amer. Urol. Assn. So proud to be a part of this group!

A great walk to support #Bladderca by
@IBCG_BladderCA@AmerUrological
#AUA -IBCG #AUA 24 Thx Ashish M. Kamat, MD, MBBS
for coordinating! Prof Param Mariappan
Petros Grivas Sia Daneshmand, M.D.
Sarah P. Psutka MD MS Roger Li Patrick Hensley, MD
Joan Palou Redorta World Bladder Cancer Patient Coalition
@bean_chisolm Karima Oualla, MD,MSc Carme Mir

Optimal #TURBT : Do skilled urologists really need to perform reTUR for all HG patients? Neal Shore moderates a debate between Jeremy Teoh CUHK Medicine and Badrinath Konety, MD, MBA Allina Health. #AUA24 coverage with Zach Klaassen > bit.ly/4boKdTu #AUAIBCGBladderCancerForum Ashish M. Kamat, MD, MBBS

The microbiome's impact on the immunotherapy of genitourinary cancers. Join Sumanta K. Pal, MD, FASCO City of Hope and Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center as they discuss foundational research into the influence of the gut #microbiome on #GUCancers and immunotherapy > bit.ly/3HPHdCR

Can we settle the debate on PLND in radical cystectomy? John Taylor moderates Seth Lerner and Sia Daneshmand, M.D.. #AUA24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3JR4xkB Ashish M. Kamat, MD, MBBS IBCG #BladderCancerForum Keck Medicine of USC BCMHouston

Management of recurrent low-grade intermediate-risk bladder tumors. Sarah P. Psutka MD MS and Prof Param Mariappan #AUA24 #debate . Written coverage by Zach Klaassen > bit.ly/3JQVpMZ IBCG #BladderCancerForum Ashish M. Kamat, MD, MBBS

Role of urinary markers in surveillance of #NMIBC patients. Presented by Kamal Pohar, MD Ohio State Wexner Medical Center Urology Dept. and Kelly Bree MD Anderson Cancer Center discuss during the #AUA24 IBCG #BladderCancerForum . Written coverage by Zach Klaassen > bit.ly/3UQzqMD Ashish M. Kamat, MD, MBBS

This may be the most awesome thing that we have ever seen on Twitter. We are so grateful and thank you to everyone, especially Prof Param Mariappan Ashish M. Kamat, MD, MBBS Shilpa Gupta Petros Grivas Janet Kukreja Amanda Myers Andrea Necchi Sarah P. Psutka MD MS Jeremy Teoh Jennifer Regala Yüksel Ürün…

Was a great debate about 1st line treatment for LA/metastatic bladder cancer Shilpa Gupta IBCG Ashish M. Kamat, MD, MBBS Chiara Mercinelli UroToday.com

Diversity and global representation at its best in the IBCG Amer. Urol. Assn. #AUA -IBCG #Bladderca forum!
Ashish M. Kamat, MD, MBBS Joan Palou Redorta Petros Grivas Janet Kukreja Karima Oualla, MD,MSc Prof Param Mariappan Petros Grivas Chiara Mercinelli Andrea Necchi Philippe spiess

Our MD Anderson Cancer Center APP team shines at #AUA24 ! Catch their insights into APP initiatives & how Amer. Urol. Assn. offers valuable opportunities for their growth

Tamika Williams, MCMSc, PA-C Brandon Sterling, PhD, APRN Stephen Swisher Brian F. Chapin Neema Navai Lenaine Westney Kelly Bree John W. Davis, MD Curtis Pettaway, MD #OncSurgery

We are truly a global organization
Not just words, deeds

#AUA24 #TogetherWeRise

Karima Oualla, MD,MSc Shilpa Gupta Ashish M. Kamat, MD, MBBS Amanda Myers Janet Kukreja Petros Grivas Roger Li Patrick Hensley, MD Sima Porten Amer. Urol. Assn.

#PIVOT -006: A new chapter in #BladderCancer treatment. Mark Tyson Mayo Clinic joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss CG Oncology, Inc.'s advancements in bladder cancer treatment, focusing on the PIVOT study and other trials. #WatchNow on UroToday > bit.ly/3weGl8m

Amer. Urol. Assn. Ashish M. Kamat, MD, MBBS IBCG This is amazing! Thank you everyone, we are stronger together #BladderCancerMonth24

Thanks to you too, Dave, for all your hard work in making #AUA2024 a success!
Looking forward to #AUA2025

Dave Penson Amer. Urol. Assn.

OncoAlert OncLive.com Amer. Urol. Assn. IBCG IBCN Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition Stephanie Chisolm, PhD wonderful walk for awareness #AUA24 Ashish M. Kamat, MD, MBBS Shilpa Gupta Prof Param Mariappan Joan Palou Redorta Roger Li Sarah P. Psutka MD MS Fred Hutchinson Cancer Center Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Sia Daneshmand, M.D. Dr. Bishoy M. Faltas

I had the privilege to participate to the IBCG-AUA Bladder Cancer Forum and debate with my dear Shilpa Gupta on the new standards in 1st line treatment for advanced bladder cancer

IBCG Amer. Urol. Assn. Bladder Cancer Advocacy Network Ashish M. Kamat, MD, MBBS Amanda Myers Petros Grivas
#AUA24